DNA methylation and cancer therapy: new developments and expectations.
about
Linking epithelial-to-mesenchymal-transition and epigenetic modificationsDysregulated transcriptional and post-translational control of DNA methyltransferases in cancerDNA demethylation and invasive cancer: implications for therapeutics14-3-3 proteins--an updateBiomarkers in cancer staging, prognosis and treatment selectionEpigenetics and human disease: translating basic biology into clinical applicationsRTA promoter demethylation and histone acetylation regulation of murine gammaherpesvirus 68 reactivationA phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumorsEpigenetic regulation of miR-212 expression in lung cancer.Pathogenetic mechanisms in gastric cancer.Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancerGemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety.Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinomaExtensive and varied modifications in histone H2B of wild-type and histone deacetylase 1 mutant Neurospora crassaDecitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.The MethDet: a technology for biomarker developmentImproved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancerMechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.Personalised medicine for cancer: from drug development into clinical practice.Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.Genetic alterations in urothelial bladder carcinoma: an updated review.DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer.DNA methylation in breast and colorectal cancers.Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach.Global levels of histone modifications predict prognosis in different cancers.The application of delivery systems for DNA methyltransferase inhibitors.Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.Molecular targets for radiation oncology in prostate cancer.Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes.Methylation kinetics and CpG-island methylator phenotype status in colorectal cancer cell lines.Relationship between aberrant methylation of FAS promoter and biological behavior of bladder urothelial carcinoma.The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk.Rapid and specific hypomethylation of enhancers in endothelial cells during adaptation to cell culturingZebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cellsInvestigation of methylation and protein expression of the Runx3 gene in colon carcinogenesis.Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?5-Azacytidine mediated reactivation of silenced transgenes in potato (Solanum tuberosum) at the whole plant level.
P2860
Q26824575-EC28B231-7C3A-4AA4-BA89-CA8A1B6D14ABQ26827297-7E200D2C-8073-4A8D-AC77-A4FACEF5EB96Q27011914-8F3AEAF4-8DF0-415F-BB28-5BDBEEDA9DF4Q28247242-00C40806-F4A4-4F29-BA9B-DE5E73DC28BFQ28278305-F1D85EAD-3AD4-4537-83D7-DCEE79BEF8FFQ28768502-F298243D-870C-45FF-9BE0-8F6281B9E351Q33411313-499F4FC7-0252-4871-846C-85945622D090Q33752772-137C034B-4119-4E86-BFB5-98FE80FDFF20Q34081763-8BBA8490-45D0-43DE-851D-A288FA2A1D2CQ34326627-20DE2E82-0233-46A8-B0E7-FA89F08614E0Q34449043-8D440F87-440B-4B73-AA67-B1ECEC52D755Q34557714-706D41BD-472E-41E4-A696-7C00F85F3AFEQ35029955-BEACF90F-F737-4328-A6D7-8E431E920F92Q35031576-C69FD939-92F9-4293-9FA3-79AE169CA304Q35589288-D058E73C-6F4F-4180-95D0-CD7D59C2A0E1Q35597591-FFECCF94-3517-478E-BBB0-662675C78282Q35645559-BDF3D0BC-5D1E-4431-A8A2-DE720E581C63Q35945177-E5F8655B-7738-4C42-81C1-FB7D0DA7A1CCQ36221957-51D208EE-0BE9-4C7D-B64B-C57041A4BE5BQ36350870-07F5537E-638D-4F00-AC6E-9F91CDE502F3Q36365099-C2C8850C-F049-4AC7-BC09-15EF0CD087DDQ36393012-04A7C69A-6EF7-460C-B804-86744EA59BDBQ36471888-CD401032-E61B-4769-93CC-00A462838102Q36803766-A545206A-508E-44C2-B797-D4CD8E9FC17BQ37102684-4D74DF80-65B1-4CB1-9576-0E077EBE7566Q37164151-B14BB8D1-9154-4911-B1E4-81303E7EF7BDQ37911496-B7878287-96B1-4895-BD84-922642B6D89FQ37962016-539DD691-AB8D-425A-81A5-E7B1014AB21DQ38014447-DED30C27-813B-43B1-BA6E-BAAD1812F62AQ38889577-DAD3AE7E-3498-44BA-9F2F-95FB07DA81DEQ38947660-DE741784-BE0E-440E-8115-69624586F714Q39140625-10D67142-6954-4278-9300-D409D63D97A6Q39427597-4BD8B2D1-FAAE-4F02-B658-72FB397476D3Q40102564-2C11A78D-A847-4EB8-9E1F-58789D41A0BDQ40218154-2F7E5E96-CCF2-468E-9CA3-289AF28F8E86Q41590816-A3B16BF4-F878-45A2-A4D6-4AAAECBABEBAQ41858565-C7376B9F-3398-4134-854C-709C3B4B5017Q41879990-D61FE263-DE2E-4AA5-A2D2-D2C6F4F61AB8Q45419283-128E6424-935A-42F6-84B6-75D383EDCCBEQ48135912-DB22C1C0-3FB5-4C25-BB2F-BCCE90E84AE9
P2860
DNA methylation and cancer therapy: new developments and expectations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
DNA methylation and cancer therapy: new developments and expectations.
@ast
DNA methylation and cancer therapy: new developments and expectations.
@en
type
label
DNA methylation and cancer therapy: new developments and expectations.
@ast
DNA methylation and cancer therapy: new developments and expectations.
@en
prefLabel
DNA methylation and cancer therapy: new developments and expectations.
@ast
DNA methylation and cancer therapy: new developments and expectations.
@en
P1476
DNA methylation and cancer therapy: new developments and expectations.
@en
P356
10.1097/01.CCO.0000147383.04709.10
P577
2005-01-01T00:00:00Z